An estimated 1,000 babies in the United States and 50,000 babies worldwide are born with Spina Bifida each year. While the exact cause is not known, it likely involves multiple factors: genetic, nutritional and environmental. Previous research has established that folic acid, known as vitamin B9, can halve the risk of Spina Bifida when taken by women prior to conception of a child. Just how B9 reduces risk, however, remains a mystery, and Spina Bifida remains irreversible.
The Gleeson Lab at UC San Diego is working to set up an international registry of patients with Spina Bifida and fund new studies investigating how folic acid reduces the risk. This study is supported by a National Institute of Health (NIH) awarded grant from the NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development.
In cooperation with the Spina Bifida Association, Shriner’s Children’s Hospitals, and spina bifida clinics throughout the world, we aim to identify potential causes and underlying mechanisms of this birth defect. We hope these discoveries will lead to prevention of Spina Bifida as well as expanded use of folate by other countries to help them reduce its incidence
Our study is actively recruiting participants who fulfill the criteria below:
• Diagnosed with spina bifida (myelomeningocele, meningocele, lipomeningocele)
*excluded: spina bifida occulta
• Participant can be of any age
• Diagnosed with spina bifida
• Participant and biological parents are willing and able to send saliva samples by mail
• Participant and any living biological parent in the case of deceased or absent parents are willing to send saliva samples by mail. **
For more information:
1. Visit
https://www.gleesonlab.ucsd.edu 2. Email gleesonlab@health.ucsd.edu
3. Call (858) 246-0547
** If you are participating without one or both parents in our genetic analysis, please note that we may obtain less detailed information with less participating members compared to families participating as trios. Our focus is on identifying new genetic mutations in the child that are not present in the parents. While we may have more comprehensive results with familial trios, your contribution is still essential, and we appreciate your involvement in spina bifida research!